Quest PharmaTech Inc. (TSXV:QPT)

Canada flag Canada · Delayed Price · Currency is CAD
0.0500
0.00 (0.00%)
Apr 22, 2025, 4:00 PM EDT
25.00%
Market Cap 8.46M
Revenue (ttm) n/a
Net Income (ttm) -2.09M
Shares Out 169.13M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 262,300
Average Volume 131,783
Open 0.0500
Previous Close 0.0500
Day's Range 0.0500 - 0.0500
52-Week Range 0.0200 - 0.0600
Beta 0.22
RSI 55.18
Earnings Date May 29, 2025

About Quest PharmaTech

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company’s lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for the potential cancer targets include pancreatic, colon, leukemia, ovarian, and breast cancer. It is also involved in the development of Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. The company is headquartered in Edmonton, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Ragupathy Madiyalakan
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol QPT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.